Patents Assigned to DexCom
  • Patent number: 11769589
    Abstract: This disclosure provides systems, methods and apparatus for processing, transmitting and displaying data received from an analyte sensor, such as a glucose sensor. The system may include a display device with at least one input device. In response to movement of or along the input device, the display device may change a glucose data output parameter and update an output of the display device using the changed output parameter.
    Type: Grant
    Filed: December 10, 2021
    Date of Patent: September 26, 2023
    Assignee: Dexcom, Inc.
    Inventors: Eric Johnson, Michael Robert Mensinger, Peter C. Simpson, Thomas Hall, Hari Hampapuram, Kostyantyn Snisarenko, Eli Reihman, Holly Chico, Kassandra Constantine
  • Patent number: 11766194
    Abstract: Systems and methods are provided to provide guidance to a user regarding management of a physiologic condition such as diabetes. The determination may be based upon a patient glucose concentration level. The glucose concentration level may be provided to a stored model to determine a state. The guidance may be determined based at least in part on the determined state.
    Type: Grant
    Filed: February 6, 2019
    Date of Patent: September 26, 2023
    Assignee: Dexcom, Inc.
    Inventors: Alexandra Elena Constantin, Scott M. Belliveau, Naresh C. Bhavaraju, Jennifer Blackwell, Eric Cohen, Basab Dattaray, Anna Leigh Davis, Rian Draeger, Arturo Garcia, John Michael Gray, Hari Hampapuram, Nathaniel David Heintzman, Lauren Hruby Jepson, Matthew Lawrence Johnson, Apurv Ullas Kamath, Katherine Yerre Koehler, Phil Mayou, Patrick Wile McBride, Michael Robert Mensinger, Sumitaka Mikami, Andrew Attila Pal, Nicholas Polytaridis, Philip Thomas Pupa, Eli Reihman, Peter C. Simpson, Tomas C. Walker, Daniel Justin Wiedeback, Subrai Girish Pai, Matthew T. Vogel
  • Patent number: 11770863
    Abstract: Systems, devices, and methods are disclosed for wireless communication of analyte data. In this regard, in embodiments, a mobile includes a transceiver configured to transmit and receive wireless signals. The mobile device includes circuitry operatively coupled to the transceiver. The mobile device also includes a non-transitory computer-readable medium operatively coupled to the circuitry and storing instructions that, when executed, cause the mobile device to perform a number of operations. One such operation is to obtain a derivative of a first signal received via a first link. Another such operation is to obtain a derivative of a second signal received via a second link; and. Yet another such operation is to generate a selection for connection to an analyte sensor system, based on a comparison of the derivative of the first signal and the derivative of the second signal.
    Type: Grant
    Filed: November 24, 2021
    Date of Patent: September 26, 2023
    Assignee: Dexcom, Inc
    Inventors: Aditya Mandapaka, Douglas William Burnette, Hari Hampapuram, Francis William Pascual, James Stephen Amidei, Darin Edward Chum Dew, Apurv Ullas Kamath, Nathanael Paul, William A. Pender, Michael A. Ploof
  • Publication number: 20230284944
    Abstract: Flexible analyte sensors are provided. Flexible analyte sensors may be flexible continuous analyte sensors that facilitate continuous monitoring of an analyte such as blood glucose. The flexible analyte sensor may have a relatively flexible conductive or non-conductive core, may be formed from a plurality of substantially planar layers, or may be configured to transform from a freestanding sensor ex vivo to a non-freestanding sensor in vivo.
    Type: Application
    Filed: May 16, 2023
    Publication date: September 14, 2023
    Applicant: Dexcom, Inc.
    Inventors: Shanger Wang, Devon M. Headen, Sebastian Bohm, Jonathan Hughes, Ted Tang Lee, Peter C. Simpson, Jiong Zou
  • Patent number: 11756682
    Abstract: The present disclosure relates to techniques for receiving glucose data from a continuous glucose sensor and controlling the use and redistribution of that data so it is used in an intended manner. In one aspect, a system includes a plurality of continuous glucose monitor (CGM) devices; a plurality of display devices to receive data from the CGM devices classified into a plurality of classifications based on data type; a cloud server architecture to receive the data from the display devices on an intermittent basis, in which the data routed to a particular server of the plurality of servers is determined by the data type, and in which the intermittent basis varies depending upon data type; a plurality of remote monitor display devices; and an analysis and report engine.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: September 12, 2023
    Assignee: Dexcom, Inc.
    Inventors: Michael Robert Mensinger, Eric Cohen, Basab Dattaray, Hari Hampapuram, Apurv Ullas Kamath, Stephen M. Madigan, Phil Mayou
  • Patent number: 11749408
    Abstract: A mathematical model of type 1 diabetes (T1D) patient decision-making can be used to simulate, in silico, realistic glucose/insulin dynamics, for several days, in a variety of subjects who take therapeutic actions (e.g. insulin dosing) driven by either self-monitoring blood glucose (SMBG) or continuous glucose monitoring (CGM). The decision-making (DM) model can simulate real-life situations and everyday patient behaviors. Accurate submodels of SMBG and CGM measurement errors are incorporated in the comprehensive DM model. The DM model accounts for common errors the patients are used to doing in their diabetes management, such as miscalculations of meal carbohydrate content, early/delayed insulin administrations and missed insulin boluses. The DM model can be used to assess in silico if/when CGM can safely substitute SMBG in T1D management, to develop and test guidelines for CGM driven insulin dosing, to optimize and individualize off-line insulin therapies and to develop and test decision support systems.
    Type: Grant
    Filed: October 20, 2021
    Date of Patent: September 5, 2023
    Assignee: DEXCOM, INC.
    Inventors: Martina Vettoretti, Andrea Facchinetti, Giovanni Sparacino, Claudio Cobelli
  • Patent number: 11744943
    Abstract: Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated.
    Type: Grant
    Filed: April 17, 2020
    Date of Patent: September 5, 2023
    Assignee: DexCom, Inc.
    Inventors: John Michael Dobbles, Apurv Ullas Kamath, Aarthi Mahalingam, James H. Brauker
  • Patent number: 11737692
    Abstract: Disclosed herein are devices, systems, and methods for a continuous analyte sensor, such as a continuous glucose sensor. In certain embodiments disclosed herein, various in vivo properties of the sensor's surroundings can be measured. In some embodiments, the measured properties can be used to identify a physiological response or condition in the body. This information can then be used by a patient, doctor, or system to respond appropriately to the identified condition.
    Type: Grant
    Filed: May 22, 2020
    Date of Patent: August 29, 2023
    Assignee: Dexcom, Inc.
    Inventors: Naresh C. Bhavaraju, Sebastian Bohm, Robert J. Boock, Daiting Rong, Peter C. Simpson
  • Patent number: 11730407
    Abstract: Devices and methods are described for providing continuous measurement of an analyte concentration. In some embodiments, the device has a sensing mechanism and a sensing membrane that includes at least one surface-active group-containing polymer and that is located over the sensing mechanism. The sensing membrane may have a bioprotective layer configured to substantially block the effect and/or influence of non-constant noise-causing species.
    Type: Grant
    Filed: January 24, 2022
    Date of Patent: August 22, 2023
    Assignee: Dexcom, Inc.
    Inventors: Robert Boock, Monica Rixman Swinney, Huashi Zhang, Michael J. Estes, Kristina Lawrence
  • Patent number: 11730402
    Abstract: Systems and methods for a continuous monitoring of analyte values received from an analyte sensor system are provided. One method for a wireless data communication between an analyte sensor system and a mobile device involves storing identification information associated with a transceiver of the analyte sensor system, the identification information entered by a user of the mobile device via a custom application running on the mobile device; causing the custom application to enter a background mode; searching for advertisement signals; receiving an advertisement signal from the transceiver; authenticating the transceiver based on the identification information; prompting the user to bring the custom application to a foreground mode; causing the custom application to request a confirmation from the user that a data connection with the transceiver is desired; receiving the confirmation from the user; and completing the data connection with the transceiver.
    Type: Grant
    Filed: June 14, 2022
    Date of Patent: August 22, 2023
    Assignee: Dexcom, Inc.
    Inventors: Jose Hector Hernandez-Rosas, Shawn Larvenz, Mark Dervaes, Indrawati Gauba, Michael Robert Mensinger, Eric Cohen, Brian Christopher Smith, Jorge Valdes, Jacob S. Leach
  • Patent number: 11723560
    Abstract: Systems and methods are provided to provide guidance to a user regarding management of a physiologic condition such as diabetes. The determination may be based upon a patient glucose concentration data sensed by a glucose concentration sensor. A host state change associated with the host glucose concentration data may be determined. A guidance message based at least in part on the host state change may also be determined. The guidance message may be delivered through a user interface.
    Type: Grant
    Filed: February 6, 2019
    Date of Patent: August 15, 2023
    Assignee: Dexcom, Inc.
    Inventors: Alexandra Elena Constantin, Scott M. Belliveau, Naresh C. Bhavaraju, Jennifer Blackwell, Eric Cohen, Basab Dattaray, Anna Leigh Davis, Rian Draeger, Arturo Garcia, John Michael Gray, Hari Hampapuram, Nathaniel David Heintzman, Lauren Hruby Jepson, Matthew Lawrence Johnson, Apurv Ullas Kamath, Katherine Yerre Koehler, Phil Mayou, Patrick Wile McBride, Michael Robert Mensinger, Sumitaka Mikami, Andrew Attila Pal, Nicholas Polytaridis, Philip Thomas Pupa, Eli Reihman, Peter C. Simpson, Tomas C. Walker, Daniel Justin Wiedeback
  • Patent number: 11717193
    Abstract: Examples of invasive biosensor alignment and retention features and methods are described. One example biosensor includes a housing comprising: a first surface defining a first opening, and a second surface opposite the first surface, the second surface defining a second opening, the first and second openings defining a substantially unobstructed pathway through the housing; a biosensor wire partially disposed within the housing and having an exterior portion extending through the first opening; a hollow insertion needle positioned within the pathway and extending through the first opening, the hollow insertion needle at least partially encircling the biosensor wire; and a biosensor retention feature collapsible against the first surface of the housing, the biosensor retention feature encircling and contacting the hollow insertion needle.
    Type: Grant
    Filed: February 2, 2021
    Date of Patent: August 8, 2023
    Assignee: DexCom, Inc.
    Inventors: Arthur Lin, Xianyan Wang, Pey-Jiun Ko
  • Patent number: 11714060
    Abstract: Systems and methods are provided that address the need to frequently calibrate analyte sensors, according to implementation. In more detail, systems and methods provide a preconnected analyte sensor system that physically combines an analyte sensor to measurement electronics during the manufacturing phase of the sensor and in some cases in subsequent life phases of the sensor, so as to allow an improved recognition of sensor environment over time to improve subsequent calibration of the sensor.
    Type: Grant
    Filed: May 2, 2019
    Date of Patent: August 1, 2023
    Assignee: Dexcom, Inc.
    Inventors: Naresh C. Bhavaraju, Becky L. Clark, Vincent P. Crabtree, Chris W. Dring, Arturo Garcia, Jason Halac, Jonathan Hughes, Jeff Jackson, Lauren Hruby Jepson, David I-Chun Lee, Ted Tang Lee, Rui Ma, Zebediah L. McDaniel, Jason Mitchell, Andrew Attila Pal, Daiting Rong, Disha B. Sheth, Peter C. Simpson, Stephen J. Vanslyke, Matthew D. Wightlin, Anna Leigh Davis, Hari Hampapuram, Aditya Sagar Mandapaka, Alexander Leroy Teeter, Liang Wang
  • Patent number: 11712182
    Abstract: Multi-state engagement with continuous glucose monitoring (CGM) systems is described. Given the number of people that wear CGM systems and because CGM systems produce measurements continuously, a platform that provides a CGM system may have an enormous amount of data. This amount of data is practically, if not actually, impossible for humans to process. In implementations, a CGM platform includes a data analytics platform that obtains packages of glucose measurements provided by a CGM system and also obtains additional data associated with a user. The data analytics platform generates state information for the user by processing these CGM packages and the additional data, at least in part, by using one or more models. Based on this state information, the data analytics platform controls communication with the user, which may include generating intervention strategies to prevent users from transitioning to a negative state such as discontinuing use of the CGM system.
    Type: Grant
    Filed: December 7, 2020
    Date of Patent: August 1, 2023
    Assignee: Dexcom, Inc.
    Inventors: Andrew Scott Parker, Annika Emilie Kristina Jimenez, Chad Patterson, Subrai Girish Pai, Apurv Ullas Kamath
  • Patent number: 11706876
    Abstract: Pre-connected analyte sensors are provided. A pre-connected analyte sensor includes a sensor carrier attached to an analyte sensor. The sensor carrier includes a substrate configured for mechanical coupling of the sensor to testing, calibration, or wearable equipment. The sensor carrier also includes conductive contacts for electrically coupling sensor electrodes to the testing, calibration, or wearable equipment.
    Type: Grant
    Filed: April 12, 2022
    Date of Patent: July 18, 2023
    Assignee: DexCom, Inc.
    Inventors: Jason Halac, John Charles Barry, Chris W. Dring, David A. Keller, Craig Thomas Gadd, Kyle Thomas Stewart
  • Patent number: 11696710
    Abstract: Sensor devices including dissolvable tissue-piercing tips are provided. The sensor devices can be used in conjunction with dissolvable needles configured for inserting the sensor devices into a host. Hardening agents for strengthening membranes on sensor devices are also provided. Methods of using and fabricating sensor devices are also provided.
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: July 11, 2023
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, Jennifer Blackwell, Sebastian Bohm, Michael J. Estes, Jeff Jackson, Jason Mitchell, Jack Pryor, Daiting Rong, Sean T. Saint, Disha B. Sheth, Shanger Wang
  • Patent number: 11696706
    Abstract: Multi-state engagement with continuous glucose monitoring (CGM) systems is described. Given the number of people that wear CGM systems and because CGM systems produce measurements continuously, a platform that provides a CGM system may have an enormous amount of data. This amount of data is practically, if not actually, impossible for humans to process. In implementations, a CGM platform includes a data analytics platform that obtains packages of glucose measurements provided by a CGM system and also obtains additional data associated with a user. The data analytics platform generates state information for the user by processing these CGM packages and the additional data, at least in part, by using one or more models. Based on this state information, the data analytics platform controls communication with the user, which may include generating intervention strategies to prevent users from transitioning to a negative state such as discontinuing use of the CGM system.
    Type: Grant
    Filed: December 7, 2020
    Date of Patent: July 11, 2023
    Assignee: Dexcom, Inc.
    Inventors: Andrew Scott Parker, Annika Emilie Kristina Jimenez, Chad Patterson, Subrai Girish Pai, Apurv Ullas Kamath
  • Patent number: 11696728
    Abstract: An amount of glycemic dysfunction associated with mis-timing (e.g., delay) of meal boluses based on replay analysis is determined. The amount of dysfunction of historical or estimated bolusing as compared to an optimally timed bolus based on the replay analysis is quantified and visualized. Inferences may be made about diabetes meal management regarding inputs from a patient.
    Type: Grant
    Filed: December 19, 2019
    Date of Patent: July 11, 2023
    Assignee: Dexcom, Inc.
    Inventors: Stephen D. Patek, Stephen J. Vanslyke
  • Publication number: 20230210411
    Abstract: Systems and methods described provide dynamic and intelligent ways to change the required level of user interaction during use of a monitoring device. The systems and methods generally relate to real time switching between a first or initial mode of user interaction and a second or new mode of user interaction. In some cases, the switching will be automatic and transparent to the user, and in other cases user notification may occur. The mode switching generally affects the user’s interaction with the device, and not just internal processing. The mode switching may relate to calibration modes, data transmission modes, control modes, or the like.
    Type: Application
    Filed: February 28, 2023
    Publication date: July 6, 2023
    Applicant: Dexcom, Inc.
    Inventors: Naresh C. Bhavaraju, Michael A. Bloom, Leif N. Bowman, Alexandra Lynn Carlton, Katherine Yerre Koehler, Hari Hampapuram, Jonathan Hughes, Lauren Hruby Jepson, Apurv Ullas Kamath, Anna Leigh Rack-Gomer, Peter C. Simpson, Stephen J. Vanslyke
  • Patent number: 11690537
    Abstract: An analyte sensor system is provided. The system includes a base configured to attach to a skin of a host. The base includes an analyte sensor configured to generate a sensor signal indicative of an analyte concentration level of the host, a battery, and a first plurality of contacts. The system includes a sensor electronics module configured to releasably couple to the base. The sensor electronics module includes a second plurality of contacts, each configured to make electrical contact with a respective one of the first plurality of contacts, and a wireless transceiver configured to transmit a wireless signal based at least in part on the sensor signal. The system includes a first sealing member configured to provide a seal around the first and second plurality of contacts within a first cavity. Related analyte sensor systems, analyte sensor base assemblies and methods are also provided.
    Type: Grant
    Filed: May 3, 2019
    Date of Patent: July 4, 2023
    Assignee: DexCom, Inc.
    Inventors: Neel Narayan Shah, John Michael Gray, Jason Halac, Carl Erich Hoffmeier, Neal Davis Johnston, Nicholas Kalfas